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Summary The expression of Group-TI phospholipase A2 (M-PLA2) was analysed immunohistochemically in
malignant, non-malignant (including atrophic, hyperplastic, pseudopyloric metaplastic and intestinal metaplas-
tic) and normal human gastric mucosae. M-PLA2 was consistently detected in the stem cell lineage,
pseudopyloric metaplasia and the generative cells of hyperplastic foveolar epithelium and intestinal metaplasia
(IM). In IM, the appearance of M-PLA2 was found to be closely related to the degree of development of the
brush borders on columnar cells and was especially prominent at dense brush borders. Paneth cells of IM,
particularly their secretory products, were strongly immunoreactive for M-PLA2. In gastric cancer, the
expression of M-PLA2 was detected exclusively in cancer cells with a low grade of differentiation, and seemed
to be intensified in the invading zone of the tumour. These observations suggest that the expression of
M-PLA2 is associated with the proliferative kinetics and regeneration of human gastric mucosa, and may
indicate a physiological relationship between its expression and metaplasia of small intestinal type. Moreover,
the appearance of M-PLA2 may be related to the invasive ability of gastric cancer.
Phospholipase A2 (PLA2) catalyses the specific hydrolysis of a
fatty acyl ester bond at the sn-2 position of glycerophos-
pholipids. In addition, a calcium-dependent PLA2 is thought
to be one of the most important enzymes regulating the
release of arachidonic acid from membrane phospholipids
(Lands, 1968; Van den Bosh, 1980). Until recently, two
genetically distinct isoenzymes, exocrine PLA2 (secreted in
pancreatic juice) and intracellular PLA2 (contained in the
cytosol and membrane-associated fraction), have been recog-
nised in humans (Vadas & Pruzanski, 1986; Nakaguchi et al.,
1986). In the membrane fraction of human spleen cells the
existence of a PLA2, which does not react with anti-human
P-PLA2 antibody, has been demonstrated (Nakaguchi et al.,
1986). Further purification and subsequent sequencing of this
enzyme revealed that it belongs to the Group-I1 PLA2
(Kanda et al., 1989). Group-II PLA2 has been thought to
play an important regulatory role in several metabolic path-
ways (Nakano et al., 1990a; Nakano et al., 1990b). And
recently, the distribution of this Group-II-PLA2 in human
organs has been published (Kiyohara et al., 1992).
The product of this enzyme's action, free arachidonate
(which serves as a substrate for the cyclo-oxygenase route
and lipoxygenase route) (Van den Bosh, 1980) is the first and
rate-limiting precursor in the biosynthes of prostaglandins
(PG), leukotriene and HETE (Lands, 1979; Van den Bosh,
1980). Among these products, PG is abundant in gastrointes-
tinal mucosa (Robert et al., 1979), and especially PGE2, has
potent cytoprotective effects, e.g. inhibition of gastric secre-
tion, prevention of ulcer formation, and acceleration of the
healing of mucosal damage (Robert et al., 1979; Wilson et
al., 1971; Robert et al., 1976). Nevertheless, the biological
significance and function of PLA2 in the human stomach is
still unknown. In the rat gastric mucosa, PLA2 which is
structurally identical to the rat pancreatic type PLA2 (P-
PLA2, Group-I PLA2) (Tojo et al., 1988; Okamoto et al.,
1985) was immunocytochemically detected in chief cells (Tat-
sumi et al., 1990). Knowledge of the distribution of this
enzyme in human gastric mucosa might provide useful
insight into the function of PLA2 in gastric mucosa.
In this study, the immunohistochemical expression of M-
PLA2 was examined by using a monoclonal antibody
(MoAb) against the recently described human splenic Group-
II PLA2 (M-PLA2) in a variety of human gastric mucosae,
such as normal, atrophic, hyperplastic, pseudopyloric meta-
plastic and intestinal metaplastic mucosae, as well as
cancerous lesions. Moreover, the possible biological role of
M-PLA2 is discussed, especially concerning the relationship
between its expression and the cell- and tissue-kinetics of
gastric mucosa.
Materials and methods
Tissues
Primary gastric cancers were obtained from 45 surgical speci-
mens of gastrectomised patients. These patients consisted of
27 males and 18 females. Their ages ranged from 32 to 85
years old (average age 66.2 years). Tissues were fixed in 10%
buffered formaldehyde for 4 days and embedded in paraffin.
One of the serial sections from each tissue was stained with
hematoxylin and eosin (H&E) for routine histologic examina-
tion, and the others were treated for the demonstration of
M-PLA2 as described below. In the 45 specimens examined,
normal foveolar epithelia of the cardia, fundus, and antrum
were found in two, nine and two cases, respectively. Normal
glands of cardia, fundus and antrum were also found in two,
six and two cases, respectively. Moreover, normal duodenal
mucosae in four cases were also studied.
Classification ofintestinal metaplastic mucosa (IM)
Intestinal metaplastic changes in gastric mucosa near and/or
adjacent to cancerous lesions were found in 32 cases. Since
IM changes were often variable even within a single speci-
men, the intestinal metaplastic ducts were classified into three
groups, according to the degree of development of the brush
border on columnar cells (Morson, 1955; Murata et al.,
1992). Thus, IMs containing densely, sparsely or undeveloped
brush borders were observed in 14, 10 and 20 sites, respec-
tively, in 32 cases.
Classification ofgastric cancer
Gastric cancers were morphologically classified into six types
according to the General Rules for the Gastric Cancer Study
of the Japanese Research Society for Gastric Cancer
(Japanese Research Society for Gastric Cancer, 1985); papil-
lary adenocarcinoma (pap), tubular adenocarcinomas of the
well (tub,) or moderately (tub2) differentiated type, poorly
differentiated adenocarcinoma (por), mucinous adenocar-
cinoma (muc), and signet-ring cell carcinoma (sig). The 45
gastric cancer tissues were classified a seven pap, eight tub1,
ten tub2, 11 por, seven sig, and three muc types.
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Monoclonal antibody (MoAb)
The MoAb anti-M-PLA2 (IgG) employed was raised in mice
immunised against M-PLA2 purified from the membrane-
fraction of human spleens (Matsuda et al., 1991).
Avidin-biotin-peroxidase complex method
ABC kits (Vector Laboratories, Inc. USA) for mouse IgG
were used. Formalin-fixed and paraffin-embedded tissue sec-
tions were deparaffinised with xylene and rehydrated with a
series of ethanol solutions. Tissue sections were incubated in
normal serum for 30 min following the block of endogenous
peroxidase activity with 1% H202 in methanol for 20 min,
incubated overnight at 4°C with optimally diluted primary
MoAb, and subsequently incubated with biotinylated anti-
mouse IgG and avidin-biotin peroxidase complex for 30 min
at room temperature. They were washed in 0.01 M phos-
phate-buffered saline (PBS, pH 7.2) between each incubation
step. The peroxidase reaction was applied using 0.01% 3,3'-
diaminobenzidine tetrahydrochloride (Sigma: St Louis, MO,
USA) in 0.05 M Tris-HCI buffer (pH 7.6). Sections were
counterstained with Mayer's hematoxylin. For the negative
control, the following procedures were employed: (1) sections
were processed without the primary antibody, and (2) mouse
IgG (M9144, Sigma: St Louis, MO, USA) was used instead
of the primary antibody.
Results
The distribution of the M-PLA2-immunoreactive cells in
human gastric and duodenal mucosa is summarised in Table I.
Normal gastric and duodenal mucosa
M-PLA2 was not expressed in the normal foveolar epithelia
of two cardiac, nine fundic, and two antral mucosae.
Similarly, M-PLA2 was not detected in two cardiac, six fun-
dic, and two antral proper glands.
In four normal duodenal mucosae, the foveolar epithelia in
all four specimens and Brunner's glands in two specimens
expressed this antigen (Figure 1). Furthermore, almost all
Paneth cells at the bottom of these crypts expressed M-PLA2
Table I Distribution of M-PLA2 immunoreactive cells in non-
malignant gastric and duodenal mucosa
No. ofpositive staining/No ofsites
1. Normal gastric mucosa
Foveolar epithelia
cardiac
fundic
antral
Gland
cardiac
fundic
antral
2. Atrophic mucosa
Foveolar epithelia
cardiac
fundic
antral
Gland
cardiac
fundic
antral
3. Hyperplastic mucosa
Foveolar epithelia
cardiac
fundic
antral
Gland
cardiac
fundic
antral
4. Pseudopyloric metaplasia
5. Generative zone
6. Intestinal metaplasia
7. Normal duodenal mucosa
Foveolar epithelia
Brunner's gland
0/2
0/9
0/2
0/2
0/6
0/2
0/0
0/3
0/1
0/0
0/16
0/2
0/0
1/2 (50.0%)
0/1
0/0
0/3
0/1
22/26 (84.6%)
16/20 (80.0%)
14/44 (45.5%)
4/4 (100%)
2/2 (100%)
Figure 1 Immunohistochemical staining for M-PLA2 in duodenal mucosa in Golgi pattern. Bar = 1I00tm.M-PLA2-EXPRESSION IN GASTRIC CANCER 105
in all four specimens. The expression of M-PLA2 in foveolar
epithelia and Brunner's glands were found in Golgi and
cytoplasmic pattern, respectively. In Paneth cells, positive
staining in a fine granular pattern was seen among the
eosinophilic granules but not in the cytoplasm. In a few
cases, mucous neck cells, which are localised to an isthmus of
gastric mucosa, were found to faintly express this antigen in
cytoplasmic granular pattern (Figure 2).
Atrophic mucosa andpseudopyloric metaplasia
Three fundic and one antral epithelia exhibiting atrophic
changes were found not to express M-PLA2. Similarly, the
atrophic glands of 16 fundic and two antral mucosae were
also negative.
Pseudopyloric metaplasia, which appears as one of the
regenerative forms following mucosal damage from gastritis
or ulceration, was observed in 26 cases, and in 22 (84.6%)
cases, M-PLA2 was expressed in Golgi pattern (Figure 3).
Furthermore, M-PLA2 appeared in Golgi pattern in 12 out of
14 (85.7%) cases with cystic degeneration of the pseudo-
pyloric glands.
Hyperplastic mucosa
Hyperplasia of the foveolar epithelia in the fundus and ant-
rum was observed in two and one case, respectively, and the
expression of M-PLA2 was seen in one fundic epithelium in
the Golgi region. At the isthmus of this positive mucosa,
which is postulated to be the generative zone of this hyper-
plastic epithelium, a strong immunoreactivity in Golgi or
cytoplasmic granular pattern was observed (Figure 4a). As
for hyperplasia of the proper glands, M-PLA2 was not ex-
pressed in three fundic nor one antral mucosae.
Figure 2 Immunohistochemical staining for M-PLA2 in the
mucous neck cells at the isthmus of gastric mucosa in Golgi
pattern. Bar = 1001tm.
Figure 3 Immunohistochemical staining for M-PLA2!in a patient
with pseudopyloric metaplasia. The stain is distributed in a Golgi
pattern. This pattern was also seen in epithelia exhibiting an
absorptive-type metaplasia as well as in cystic degeneration of the
pseudopyloric glands. The 'ABC' method described in the text
was used. Bar = 100gm.
Generative zone
When regenerative transformation occurs following mucosal
damage caused by gastritis, erosion, and ulceration, elonga-
tion of the generative zone, which consists of generative cells,
is known to occur (Wright et al., 1990). In this study, an
apparent generative zone was found in 20 cases, and M-PLA2
was demonstrated in 16 (80.0%) cases in Golgi or cytoplas-
mic granular pattern (Figure 4b). M-PLA2 was often detected
in Golgi or cytoplasmic granular pattern at the bottom of the
negative intestinal metaplastic ducts as well as above the
generative zone (Figure 4c).
Intestinal metaplastic ducts and Paneth cells
In IM near and/or adjacent to cancerous lesions, the fre-
quency of the expression of M-PLA2 in crypts with densely,
sparsely and undeveloped brush borders was 14/14 (100%),
6/10 (60.0%) and 0/20 (0%) sites, respectively. All the
positive staining of the columnar cells occurred in Golgi
pattern. Moreover, at dense brush borders, the manifest
appearance of M-PLA2 was often demonstrated (Figure 5a).
On the other hand, all of the goblet cells were negative.
Twenty-two cases of those with intestinal metaplastic ducts
had Paneth cells at and/or near the bottom of their crypts.
Twenty (87.0%) cases exhibited positive staining, and M-
PLA2 expression was observed not in the cytoplasm but
among the many secretory granules, as well as in the
duodenal mucosa (Figure Sb).
Cancerous tissues
As shown in Table II, the frequency of M-PLA2 expression
was inversely proportional to the degree of cell-differ-
entiation. The expression of this antigen was negative in
seven papillary adenocarcinomas. Positive staining was found
in one out of eight (12.5%) well differentiated tubular
adenocarcinomas (tub,) (Figure 6a).
In contrast, M-PLA2 was frequently expressed in the more
poorly differentiated cancer cells, such as the poorly106 K. MURATA et al.
a
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b
Figure 4 Immunohistochemical staining for M-PLA2 in the generative cells of gastric mucosa in Golgi or cytoplastic granular
pattern. Positive staining was observed a, at the isthmus of the positive hyperplastic foveolar epithelium. Bar = 100 Jim; b, in the
elongated zone of generative cells. Bar = 50 ltm; c, in the bottom of negative intestinal metaplastic ducts without dense brush
border. Bar = 100ILm.
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Figure 5 a, Immunohistochemical staining for M-PLA2 in a patient with IM and a dense brush border. There is prominent
staining of the brush border. There is not detectable staining of the goblet cells. Bar = 100iLm. b, Immunohistochemical staining
for M-PLA2 in a patient with IM and many Paneth cells. Heavy staining is seen among the many secretory granules of the Paneth
cells. Bar = 50jAm.
differentiated adenocarcinomas (por) and the moderately
differentiated tubular adenocarcinomas (tub2). Positive stain-
ing in por and tub2 was found in eight out of 11 (72.7%) and
four out of ten (40.0%) cases, respectively, and their staining
pattern was cytoplasmic granular (Figure 6b). The expression
of M-PLA2 seemed to be more pronounced in the invasive
areas of the tumour (Figure 6c). On the other hand, cancer
cells capable of producing mucin, such as signet-ring cell
carcinoma (sig) and mucinous adenocarcinoma (muc),
generally failed to stain with the monoclonal antibody,
although a few sig cells which were interspersed among por
faintly expressed M-PLA2-108 K. MURATA et al.
Discussion
In the present study, the expression of M-PLA2 was analysed
immunohistochemically in malignant and non-malignant
mucosae (including atrophic, hyperplastic, pseudopyloric
metaplastic and intestinal metaplastic), as well as normal
mucosa of the human stomach.
In normal gastric mucosa, M-PLA2 was expressed in
neither foveolar epithelia nor proper glands, except for
mucous neck cells which are thought to be generative cells
(stem cells) in gastric mucosa (MacDonald et al., 1964). In
contrast, the elongated zone of stem cells, which appears
following a breach in the gastrointestinal mucosa (Wright et
al., 1990), strongly expressed M-PLA2 in the same pattern.
Table II M-PLA2-expression and histopathological types of gastric
cancer
pap tub, tub2 por sig muc
O/7a 1/8a 4/10 8/1la 0/7 0/3
% 0 12.5 40.0 72.7 0 0
Exact probability test: ap<0.01.
a
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Figure 6 a, Immunohistochemical staining for M-PLA2 in a patient with a well differentiated gastric cancer. No significant
staining is observed except for some positive staining in a residual cystic pseudopyloric gland. Bar = 1I00 Lm. b, Immunohisto-
chemical staining for M-PLA2 in a patient with an undifferentiated gastric cancer. Significant staining is observed in cytoplasmic
granular pattern. Bar = 100ILm. c, Immunohistochemical staining for M-PLA2 in a patient with an invasive, undifferentiated gastric
cancer. Note the intensive staining observed in the invading zone of the tumour. Bar = I00 Lm.
Similarly, the isthmus in hyperplastic foveolar epithelia,
which is postulated to be its generative zone, exhibited
significant M-PLA2 expression. In intestinal metaplasia, M-
PLA2 was expressed in cells at the bottom of the glands,
differing from the Paneth cells found in M-PLA2-negative
metaplastic ducts. Since the generative cells in IM have been
reported to be localised at the bottom of the ducts, these
positive cells were thought to be identical with generative
cells of IM (Hattori & Fujita, 1979; Poulsen et al., 1986).
Furthermore, pseudopyloric glands, which signify gastric
regeneration (Hashimoto et al., 1983), frequently expressed
this enzyme. These results suggest an association of the
presence of M-PLA2 with cell proliferative kinetics and
regeneration of gastric mucosa. Moreover, it is tempting to
postulate that the increased expression of PLA2, stemming
from a mucosal accident or age-related changes, results in the
increased biosynthesis of prostaglandins which protects the
gastric mucosa and accelerates the healing of the mucosa
damage (Robert et al., 1979; Wilson et al., 1971; Robert et
al., 1976).
M-PLA2 was frequently expressed in IM. However, IM is
not a single entity but rather variable by a number of criteria
including morphologic (Morson, 1955), enzymatic (Shimada
et al., 1987), and mucin histochemical studies (Segura &
Montero, 1983). For example, small and large intestinal types
(or complete and incomplete) have been described. In this
study, IM was morphologically classified into three groups,
according to the degree of development of the brush border.
We found a positive association between the expression of
M-PLA2 and the extent of development of the brush border,
and dense brush borders often had substantial positive stain-
ing. In a separate study, we found that M-PLA2 was dis-
tributed in the normal human digestive tract mainly in small
intestine in a pattern similar to that seen in IM. It was not
detected in the large intestine. This suggests that the cells in
the metaplastic ducts expression M-PLA2 are physiologically
related to those in the normal small intestine which express
M-PLA2. Therefore, the results in this study may indicate the
association with the appearance of M-PLA2 and the transfor-
mation into intestinal type of gastric mucosa. And the
presence of M-PLA2 positive cells in IM might enable one to
classify it as a 'small intestinal' or 'complete' type.
The expression of M-PLA2 in a granular pattern was
observed among many secretory vesicles in almost all Paneth
cells, behaving as secretory cells. This appearance in Paneth
cells is consistent with a previous report which demonstrated
that Paneth cells secrete some digestive enzymes (Senagas-
Balas et al., 1984). Since the Paneth cell is postulated to
secrete substances affecting the growth and differentiation of
intestinal epithelia (Poulsen et al., 1986), the expression of
M-PLA2 might be related to cell proliferation not only in the
normal intestine but also in IM.
In addition, the secretory granules in the Paneth cells of
germ-free mammalian small intestine have been reported to
change subsequent to the administration of bacteria (Satoh,
1988). This hints that Paneth cells play some role in the
regulation of the bacterial milieu in the small intestine. It has
been previously demonstrated that there is no cross-
immunoreactivity between pancreatic and intestinal phos-
pholipase in rat Paneth cells (Erlandsen & Case, 1972).
Therefore, these results suggest that the cell membrane of
bacteria could be denatured by M-PLA2 expressed in Paneth
cells and the bacterial milieu might be regulated in the small
intestine and also in the complete type of IM. Moreover, the
hydrolysis catalysed by M-PLA2 may be a necessary step for
the phagocytosis of bacteria (Matsukura et al., 1979).
In a separate study, we found that M-PLA2 was expressed
in the foetal but not the adult gastric mucosa (Kiyohara et
al., 1992). Therefore, the abundant expression of M-PLA2 in
undifferentiated cancer cells supports the hypothesis that the
presence of this enzyme may be related to cell- and/or tissue-
differentiation of gastric mucosa. The expression of M-PLA2
in cancer was inversely proportional to the degree of the
carcinoma's cell-differentiation. Particularly intense staining
was seen in invasive gastric cancer as well as poorly
differentiated adenocarcinoma (por). The staining was most
pronounced at the invading zone near the centre of the
cancerous tissue. These results suggest that poorly differ-
entiated cancer cells may require the hydrolysis catalysed by
M-PLA2 to infiltrate into uninvolved and adjacent tissues.110 K. MURATA et al.
IM has been recognised as a precursor ofgastric cancer by
a number of morphologic (Morson, 1955), enzymatic
(Shimada et al., 1987), mucin histochemical (Segura &
Montero, 1983), and experimental studies (Matsukura, 1979).
This is especially true of the apparent relationship between
differentiated cancer, such as pap and tub,, and the large
intestinal (incomplete) type of IM (Murata et al., 1992;
Shimada et al., 1987). In contrast, there have been few
reports concerning the precursors of undifferentiated gastric
cancer. In the present study, M-PLA2 was absent in both
most of differentiated cancers and the incomplete type of IM
lacking Paneth cells and a brush border. However, it was
strongly positive in both undifferentiated cancer and in the
generative cells of the stomach. Undifferentiated por cancer
(but not sig) is thought to originate from the undifferentiated
cell zone of the non-metaplastic mucosa (Hattori, 1985).
Therefore, these results indicate that the generative cells may
be the precursor cells of undifferentiated gastric cancer.
Since Levine et al. (1977) first reported the release of PGE2
and PGF,4 from renal cells stimulated by epidermal growth
factor (EGF), it has been demonstrated that various
cytokines, e.g. EGF (Nolan et al., 1988), tumour necrosis
factor (Hori et al., 1989) and interleukin-l (Dayer et al.,
1990) stimulate PLA2-activity and induce the synthesis of
certain prostaglandins which regulate cell mitogenesis.
Therefore, the growth of M-PLA2-positive cancer cells,
especially those which are undifferentiated might be regulated
by prostaglandins via the activation of M-PLA2. Addi-
tionally, since some kinds of fibroblasts have been reported
to proliferate in response to prostaglandins (Nolan et al.,
1988; Handler et al., 1990), prostaglandins induced by M-
PLA2-activation could accelerate the growth of interstitial
tissue, resulting in the scirrhous changes usually observed in
advanced undifferentiated cancer. Furthermore, M-PLA2
itself could be directly related to growth and differentiation
in the human gastrointestinal tract, since P-PLA2 was
recently reported to be a growth factor (Arita et al., 1991).
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